US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 12.360
  • -1.950-13.63%
Close Mar 21 16:00 ET
  • 12.580
  • +0.220+1.78%
Post 20:01 ET
1.21BMarket Cap154.50P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
122.86%13.55M
341.33%42M
-13.35%-14.47M
56.33%-7.28M
46.01%-6.71M
-47.88%-59.27M
15.09%-17.41M
-124.62%-12.76M
-139.02%-16.67M
-79.48%-12.43M
Net income from continuing operations
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-56.75%-54.37M
50.32%-7.17M
-125.82%-14.87M
-170.56%-17.37M
-106.36%-14.96M
Depreciation and amortization
-5.90%-7.18M
11.66%-1.52M
-17.28%-1.81M
-8.89%-1.89M
-10.06%-1.97M
-2,223.82%-6.78M
-673.58%-1.72M
-22,085.71%-1.54M
-4,581.08%-1.73M
-3,678.00%-1.79M
Change In working capital
75.42%-1.81M
1.13%-10.68M
178.32%2.88M
1,021.79%3.76M
7.97%2.24M
42.28%-7.36M
11.50%-10.8M
162.18%1.03M
135.04%335K
17,158.33%2.07M
-Change in receivables
---8.18M
---7.4M
----
----
----
--0
--0
----
----
----
-Change in inventory
---5.95M
---5.76M
----
----
----
--0
--0
----
----
----
-Change in prepaid assets
-331.43%-6.19M
-278.44%-7.25M
-472.73%-504K
462.10%697K
94.83%867K
-20.99%-1.44M
-60.74%-1.92M
-163.77%-88K
155.36%124K
383.70%445K
-Change in payables and accrued expense
691.72%16.43M
186.51%7.68M
286.03%4.34M
1,268.75%3.07M
-71.74%1.34M
73.00%-2.78M
22.25%-8.88M
30.85%1.12M
183.90%224K
771.06%4.76M
-Change in other working capital
165.74%2.07M
69,566.67%2.08M
-1,033.33%-34K
61.54%-5K
100.80%25K
-145.44%-3.15M
-103.61%-3K
98.91%-3K
97.20%-13K
-400.00%-3.13M
Cash from discontinued investing activities
Operating cash flow
122.86%13.55M
341.33%42M
-13.35%-14.47M
56.33%-7.28M
46.01%-6.71M
-47.88%-59.27M
15.09%-17.41M
-124.62%-12.76M
-139.02%-16.67M
-79.48%-12.43M
Investing cash flow
Cash flow from continuing investing activities
-21.70%-106.1M
-490.80%-101.76M
136.06%16.82M
-128.12%-12.65M
92.37%-8.51M
-43,709.05%-87.18M
20,765.87%26.04M
-155,376.67%-46.64M
204,509.09%44.97M
-531,071.43%-111.55M
Net PPE purchase and sale
-221.71%-563K
-431.87%-302K
-225.58%-140K
-26.67%-38K
56.99%-83K
12.06%-175K
172.22%91K
-43.33%-43K
-36.36%-30K
-819.05%-193K
Net investment purchase and sale
-12.68%-98.04M
-471.74%-96.46M
141.76%19.46M
-128.02%-12.61M
92.43%-8.43M
---87.01M
--25.95M
---46.6M
--45M
---111.35M
Net other investing changes
---7.5M
---5M
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-21.70%-106.1M
-490.80%-101.76M
136.06%16.82M
-128.12%-12.65M
92.37%-8.51M
-43,709.05%-87.18M
20,765.87%26.04M
-155,376.67%-46.64M
204,509.09%44.97M
-531,071.43%-111.55M
Financing cash flow
Cash flow from continuing financing activities
949.41%72.4M
3,828.86%70.92M
-26.17%680K
-80.90%545K
-80.44%258K
-96.38%6.9M
-99.07%1.81M
159.19%921K
558.11%2.85M
245.26%1.32M
Proceeds from stock option exercised by employees
-56.28%3.02M
-15.07%1.53M
-26.17%680K
-80.90%545K
-80.44%258K
1,110.35%6.9M
537.81%1.81M
--921K
894.43%2.85M
--1.32M
Net other financing activities
--69.38M
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
949.41%72.4M
3,828.86%70.92M
-26.17%680K
-80.90%545K
-80.44%258K
-96.38%6.9M
-99.07%1.81M
159.19%921K
558.11%2.85M
245.26%1.32M
Net cash flow
Beginning cash position
-66.29%70.97M
-34.49%39.66M
-69.23%36.63M
-36.26%56.01M
-66.29%70.97M
250.50%210.52M
62.19%60.53M
166.91%119.02M
68.29%87.86M
250.50%210.52M
Current changes in cash
85.56%-20.15M
6.91%11.16M
105.18%3.03M
-162.21%-19.38M
87.80%-14.97M
-192.75%-139.55M
-93.97%10.44M
-704.69%-58.49M
508.91%31.16M
-1,461.70%-122.66M
End cash Position
-28.40%50.82M
-28.40%50.82M
-34.49%39.66M
-69.23%36.63M
-36.26%56.01M
-66.29%70.97M
-66.29%70.97M
62.19%60.53M
166.91%119.02M
68.29%87.86M
Free cash flow
121.85%12.99M
340.86%41.7M
-14.06%-14.61M
56.18%-7.32M
46.18%-6.79M
-47.58%-59.44M
16.05%-17.31M
-124.19%-12.81M
-138.69%-16.7M
-81.72%-12.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 122.86%13.55M341.33%42M-13.35%-14.47M56.33%-7.28M46.01%-6.71M-47.88%-59.27M15.09%-17.41M-124.62%-12.76M-139.02%-16.67M-79.48%-12.43M
Net income from continuing operations 114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M-56.75%-54.37M50.32%-7.17M-125.82%-14.87M-170.56%-17.37M-106.36%-14.96M
Depreciation and amortization -5.90%-7.18M11.66%-1.52M-17.28%-1.81M-8.89%-1.89M-10.06%-1.97M-2,223.82%-6.78M-673.58%-1.72M-22,085.71%-1.54M-4,581.08%-1.73M-3,678.00%-1.79M
Change In working capital 75.42%-1.81M1.13%-10.68M178.32%2.88M1,021.79%3.76M7.97%2.24M42.28%-7.36M11.50%-10.8M162.18%1.03M135.04%335K17,158.33%2.07M
-Change in receivables ---8.18M---7.4M--------------0--0------------
-Change in inventory ---5.95M---5.76M--------------0--0------------
-Change in prepaid assets -331.43%-6.19M-278.44%-7.25M-472.73%-504K462.10%697K94.83%867K-20.99%-1.44M-60.74%-1.92M-163.77%-88K155.36%124K383.70%445K
-Change in payables and accrued expense 691.72%16.43M186.51%7.68M286.03%4.34M1,268.75%3.07M-71.74%1.34M73.00%-2.78M22.25%-8.88M30.85%1.12M183.90%224K771.06%4.76M
-Change in other working capital 165.74%2.07M69,566.67%2.08M-1,033.33%-34K61.54%-5K100.80%25K-145.44%-3.15M-103.61%-3K98.91%-3K97.20%-13K-400.00%-3.13M
Cash from discontinued investing activities
Operating cash flow 122.86%13.55M341.33%42M-13.35%-14.47M56.33%-7.28M46.01%-6.71M-47.88%-59.27M15.09%-17.41M-124.62%-12.76M-139.02%-16.67M-79.48%-12.43M
Investing cash flow
Cash flow from continuing investing activities -21.70%-106.1M-490.80%-101.76M136.06%16.82M-128.12%-12.65M92.37%-8.51M-43,709.05%-87.18M20,765.87%26.04M-155,376.67%-46.64M204,509.09%44.97M-531,071.43%-111.55M
Net PPE purchase and sale -221.71%-563K-431.87%-302K-225.58%-140K-26.67%-38K56.99%-83K12.06%-175K172.22%91K-43.33%-43K-36.36%-30K-819.05%-193K
Net investment purchase and sale -12.68%-98.04M-471.74%-96.46M141.76%19.46M-128.02%-12.61M92.43%-8.43M---87.01M--25.95M---46.6M--45M---111.35M
Net other investing changes ---7.5M---5M--------------------------------
Cash from discontinued investing activities
Investing cash flow -21.70%-106.1M-490.80%-101.76M136.06%16.82M-128.12%-12.65M92.37%-8.51M-43,709.05%-87.18M20,765.87%26.04M-155,376.67%-46.64M204,509.09%44.97M-531,071.43%-111.55M
Financing cash flow
Cash flow from continuing financing activities 949.41%72.4M3,828.86%70.92M-26.17%680K-80.90%545K-80.44%258K-96.38%6.9M-99.07%1.81M159.19%921K558.11%2.85M245.26%1.32M
Proceeds from stock option exercised by employees -56.28%3.02M-15.07%1.53M-26.17%680K-80.90%545K-80.44%258K1,110.35%6.9M537.81%1.81M--921K894.43%2.85M--1.32M
Net other financing activities --69.38M------------------------------------
Cash from discontinued financing activities
Financing cash flow 949.41%72.4M3,828.86%70.92M-26.17%680K-80.90%545K-80.44%258K-96.38%6.9M-99.07%1.81M159.19%921K558.11%2.85M245.26%1.32M
Net cash flow
Beginning cash position -66.29%70.97M-34.49%39.66M-69.23%36.63M-36.26%56.01M-66.29%70.97M250.50%210.52M62.19%60.53M166.91%119.02M68.29%87.86M250.50%210.52M
Current changes in cash 85.56%-20.15M6.91%11.16M105.18%3.03M-162.21%-19.38M87.80%-14.97M-192.75%-139.55M-93.97%10.44M-704.69%-58.49M508.91%31.16M-1,461.70%-122.66M
End cash Position -28.40%50.82M-28.40%50.82M-34.49%39.66M-69.23%36.63M-36.26%56.01M-66.29%70.97M-66.29%70.97M62.19%60.53M166.91%119.02M68.29%87.86M
Free cash flow 121.85%12.99M340.86%41.7M-14.06%-14.61M56.18%-7.32M46.18%-6.79M-47.58%-59.44M16.05%-17.31M-124.19%-12.81M-138.69%-16.7M-81.72%-12.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+5.27%
Apple
AAPL
+1.95%
Meta Platforms
META
+1.75%
Intel
INTC
+1.25%
Microsoft
MSFT
+1.14%

Unlock the Full List